Government to proceed with review of generic drugs' filing under KORUS FTA

The government will continue to review the license application of a local pharmaceutical firm, even though the U.S. company that produced the original drug file a lawsuit over patent infringement under the free trade agreement between Korea and United States, according to an official of the health ministry on May 11.

In a recent symposium organized by the Pharmaceutical Society of Korea, Lim...